echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > A&R: B cell counts predict humoral and cellular responses to SARS-CoV-2 vaccine in patients receiving rituximab

    A&R: B cell counts predict humoral and cellular responses to SARS-CoV-2 vaccine in patients receiving rituximab

    • Last Update: 2022-08-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    OBJECTIVE: Patients with autoimmune inflammatory rheumatic disease treated with rituximab (RTX) were at higher risk of poor prognosis from COVID-19 infection and significantly impaired humoral immune responses against SARS-CoV-2 vacci.


    The complex relationship between antigen-specific B cells and T cells and the level of B cell repopulation required to achieve an anti-vaccine response remains largely unkno.


    RESULTS: Following SARS-CoV-2 vaccination, RTX-treated patients appeared to require at least 10 B cells (4% lymphocytes) per microliter of peripheral circulation to seroconvert to anti-Spike S1 I.


    Following SARS-CoV-2 vaccination, RTX-treated patients appear to require at least 10 B cells (4% lymphocytes) per microliter in peripheral circulation to seroconvert to anti-Spike S1 I.


    In RTX-treated patients, at least 10 B cells per microliter in the peripheral circulation are a candidate biomarker with a high likelihood of appropriate cellular and humoral responses following SARS-CoV-2 vaccinati.


    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.